title: Ursolic acid effect on atherosclerosis: apples and apples, or apples and oranges?
authors: Division of Endocrinology and Molecular Medicine, University of Kentucky, Lexington, KY 40536-0200, USA. Lisa.Tannock@uky.edu
authors: Lisa R
authors: LR
authors: Tannock
mesh_terms: D000818:Animals; D001018:Aortic Diseases / Q000517:prevention & control*; D017209:Apoptosis / Q000187:drug effects*; D050197:Atherosclerosis / Q000517:prevention & control*; D002317:Cardiovascular Agents / Q000494:pharmacology*; D020169:Caspases / Q000378:metabolism*; D004249:DNA Damage; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D005260:Female; D061307:Human Umbilical Vein Endothelial Cells / Q000187:drug effects*; D006801:Humans; D008297:Male; D008928:Mitochondria / Q000187:drug effects*; D009000:Monocytes / Q000187:drug effects*; D058226:Plaque, Atherosclerotic / Q000139:chemically induced*; D014315:Triterpenes / Q000494:pharmacology* / Q000633:toxicity*; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*; D000097245:Ursolic Acid
chemical_list: D002317:Cardiovascular Agents; D020169:Caspases; D014315:Triterpenes; D016159:Tumor Suppressor Protein p53; D000097245:Ursolic Acid; C495901:TP53 protein, human